Curated News
By: NewsRamp Editorial Staff
August 21, 2024
Continuous Blood Glucose Monitoring: A Game-Changer for Diabetes Management
Discuss on Reddit
Discuss on SubstackTLDR
- Continuous glucose monitoring market is projected to reach $44.6 billion by 2034, driving demand for more convenient management of diabetes.
- Continuous glucose monitoring (CGM) automatically tracks glucose 24/7 through a device worn on the body, providing real-time data for informed decisions.
- CGM devices offer a more convenient and less intrusive way to manage diabetes, potentially improving the quality of life for millions of people worldwide.
- Glucotrack, Inc. has developed a Continuous Blood Glucose Monitor (CBGM) that directly measures glucose in the blood, potentially transforming diabetes management.
Impact - Why it Matters
This news matters because diabetes is a chronic disease that affects millions of people globally. The development of a more accurate, discreet, and less burdensome CGM device has the potential to transform the lives of those with diabetes, offering a more convenient way to manage their condition.
Summary
Continuous glucose monitoring (CGM) offers a better alternative to traditional glucose meters for people with diabetes. With the market for CGM devices forecasted to reach $16.2 billion in 2024, the demand for more convenient ways to manage diabetes is evident. However, not all CGM devices are the same, each with their own limitations. Glucotrack, Inc. (NASDAQ: GCTK) has developed a Continuous Blood Glucose Monitor (CBGM) that aims to overcome these challenges by directly measuring glucose in the blood, providing a potentially less burdensome and more discreet monitoring solution.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Continuous Blood Glucose Monitoring: A Game-Changer for Diabetes Management
